Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Unknown 3

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 17Gastrointestinal 14Thoracic 3Tumor-Agnostic 1Lymphoid 1Gynecologic 1CNS 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Carcinoma, Squamous Cell 1Advanced Non-squamous Non-Small-Cell Lung Cancer 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × nedaplatin × Thoracic × Clear all
NCT05648071 2022-12-13

SPBPDC

Qianfoshan Hospital

Phase 3 Unknown
60 enrolled
Thoracic

Advanced Non-squamous Non-Small-Cell Lung Cancer

NCT02643407 2015-12-31

Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer

Guangdong Association of Clinical Trials

Phase 3 Unknown
488 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell

NCT01201044 2010-09-14

DO201001

Third Military Medical University

Phase NA Unknown
80 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡